In vitro assays for COVID-19 drug development


Service description

  • SARS-CoV-2 specific assays have been developed and are made available for the development of antiviral drugs: 
  • In vitro (Vero E6 cells or other models) :
    • Cell viability/cytotoxicity at different time points, using cell titer Glo Cytopathic effect Assessment of the CPE and determination of EC50 Viral titration by qPCR Viral titration by PFU
    • Strains of SARS-CoV-2 available: Wuhan, South African (Bêta), Brazilian (gamma), UK (Alpha), Indian (Delta), and Omicron
    • Controls: infected and uninfected cells + remdesivir
  • This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the request.
  • Compounds or library to test.

  • Further details on the project may be requested.
  • You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Antiviral activity testing of any type of drug (biological or small molecule).
  • Study following the specifications validated with the Expert.

Get started with your COVID-19 in vitro assay request

Please answer the fields below to be contacted by our team of scientists

favicon large un peu plus-1